Total Funding
24
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-24 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
339267
Renovis,is a biopharmaceutical company developing drugs to treat neurological diseases and disorders.
Acquired by 
Kyocera
Richard Scheller: Member of the Medical and Scientific Review BoardPast Role: Genentech, Senior Vice President of Research
Corey Goodman: CEOPast Role: Exelixis, Co-Founder
About the Company
Renovis, Inc. is a biopharmaceutical company developing drugs to treat neurological diseases and disorders. The Company is currently developing products for acute ischemic stroke, for the treatment of neuropathic pain, and for the treatment of acute post-operative pain.
